Protagen AG successfully joined forces with Novartis to support Clinical Development of a Novel Compound in an Autoimmune Indication DORTMUND, Germany, Dec. 20, 2016 (GLOBE NEWSWIRE) -- PROTAGEN AG, a leading provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology...

PROTAGEN Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases DORTMUND, Germany, Dec. 13, 2016 (GLOBE NEWSWIRE) -- PROTAGEN AG, a leading provider of pharma development services, companion diagnostics and novel diagnostic tests in the fields of immuno-oncology...